Treating Tobacco Dependence in Inpatient Psychiatry - 1

NCT00136812 | Completed Results DMC

• 2 other identifiers: NIDA-18691-15K23DA018691-05
• Study Type: interventional
• Target: 224
• Locations: 1 country
• Sites: 2

Brief Summary

The purpose of this study is to test in a randomized clinical trial a series of hypotheses concerning the efficacy of an extended expert-system intervention plus nicotine replacement therapy (NRT) for treating tobacco dependence among patients hospitalized on a smoke-free psychiatric unit.

Conditions

Tobacco Use Cessation; Tobacco Use Disorder

Keywords

tobacco

Outcome Measures

Primary Outcomes (1)

• 7 Day Point Prevalence of Cigarette Abstinence

  3 mo, 6 mo, 12 mo, and 18 mo post-baseline

Study Arms (2)

enhanced usual care control

NO INTERVENTION

NRT during hospitalization with brief advice to stay quit once discharged

stage-tailored intervention

EXPERIMENTAL

NRT during hospitalization with brief advice to stay quit once discharged plus a computer-delivered stage-tailored smoking cessation intervention with manual and counseling plus 10-weeks of nicotine patch available post-hospitalization

Behavioral: stage-tailored intervention

Interventions

stage-tailored intervention BEHAVIORAL

This intervention consists of nicotine patch therapy during hospitalization; a stage-based self-help manual; an individualized, expert-system, feedback report at intake, 3 months and 6 months post-hospitalization with carbon copies sent to participants' outpatient clinicians; and an individual 30-min smoking cessation counseling sessions during hospitalization. Additionally, up to 10 weeks of nicotine patch is provided to intervention participants intending to stay quit following hospital discharge.

stage-tailored intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

Sponsors & Collaborators

• Stanford University: lead
• National Institute on Drug Abuse (NIDA): collaborator
• University of California, San Francisco: collaborator

Study Sites (2)

San Francisco General Hospital

San Francisco, California, 94110, United States

Location

Langley Porter Psychiatric Institute

San Francisco, California, 94143, United States

Location

Related Publications (1)

• Barnett PG, Wong W, Jeffers A, Hall SM, Prochaska JJ. Cost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized, controlled trial. J Clin Psychiatry. 2015 Oct;76(10):e1285-91. doi: 10.4088/JCP.14m09016.

  PMID: 26528651 RESULT

MeSH Terms

Conditions

Tobacco Use Cessation; Tobacco Use Disorder

Condition Hierarchy (Ancestors)

Health Behavior; Behavior; Substance-Related Disorders; Chemically-Induced Disorders; Mental Disorders

Results Point of Contact

• Title: Judith Prochaska, PhD, MPH; Associate Professor
• Organization: Stanord University

JPro@stanford.edu

650-724-3608

Study Officials

• Judith Prochaska

  University of California, San Francisco

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Study Record Dates

• First Submitted: August 25, 2005
• First Posted: August 29, 2005
• Study Start: July 1, 2006
• Primary Completion: April 1, 2011
• Study Completion: April 1, 2011
• Last Updated: April 11, 2024
• Results First Posted: March 23, 2016

Record last verified: 2024-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (2)